![](/img/cover-not-exists.png)
P846 ATLAS 2: a double-blind, randomised, active controlled, multinational Phase 3 study comparing telavancin with vancomycin for the treatment of patients with complicated skin and skin structure infections
G.R. Corey, M.E. Stryjewski, V.G. Fowler Jr, O. Teglia, A. Hopkins, M.M. Kitt, S.L. BarriereVolume:
29
Year:
2007
Language:
english
DOI:
10.1016/s0924-8579(07)70687-8
File:
PDF, 79 KB
english, 2007